Table 4 Histology information of papers included in systematic review
From: Prediction of resistance to chemotherapy in ovarian cancer: a systematic review
Study | Sub-type | Stage |
|---|---|---|
Jeong et al. [22] | Serous, Endometrioid, Adenocarcinoma | I, II, III, IV |
Lisowska et al. [23] | Serous, Endometrioid, Clear cell, Undifferentiated | II, III, IV |
Roque et al. [24] | Serous, Endometrioid, Clear cell, Undifferentiated, Mixed | IIIC, IV |
Li et al. [3] | Serous, Endometrioid, Clear cell, Mucinous, Transitional | II, III, IV |
Schwede et al. [25] | Serous, Endometrioid, Clear cell, Mucinous, Adenocarcinoma, OSE | I, II, III, IV |
Verhaak et al. [26] | NS | II, III, IV |
Obermayr et al. [27] | Serous, Non-serous | II, III, IV |
Han et al. [28] | Serous, Endometrioid, Clear cell, Mucinous, Mixed, Poorly differentiated | II, III, IV |
Hsu et al. [29] | NS | III, IV |
Lui et al. [30] | Serous | II, III, IV |
Kang et al. [31] | Serous | I, II, III, IV |
Gillet et al. [32] | Serous | III, IV |
Ferriss et al. [33] | Serous, Clear cell, Other | III, IV |
Brun et al. [34] | Serous, Endometrioid, Clear cell, Mucinous, Other | III, IV |
Skirnisdottir and Seidal [35] | Serous, Endometrioid, Clear cell, Mucinous, Anaplastic | I, II |
Brenne et al. [36] | Serous, Endometrioid, Clear cell, Undifferentiated, Mixed | II, III, IV |
Sabatier et al. [37] | Serous, Endometrioid, Clear cell, Mucinous, Undifferentiated, Mixed | I, II, III, IV |
Gillet et al. [38] | Serous | III, IV, NS |
Chao et al. [39] | NS | NS |
Schlumbrecht et al. [40] | Serous | III, IV |
Glaysher et al. [41] | Serous, Endometrioid, Clear cell, Mucinous, Mixed, Poorly differentiated | IIIC, IV |
Yan et al. [42] | Serous, Endometrioid, Clear cell, Mucinous, Transitional | II, III, IV |
Yoshihara et al. [43] | Serous | III, IV |
Williams et al. [44] | Serous, Endometrioid, Undifferentiated | III, IV |
Denkert et al. [45] | Serous, Non-serous, Undifferentiated | I, II, III, IV |
Matsumura et al. [46] | Serous | I, II, III, IV |
Crijns et al. [47] | Serous | III, IV |
Mendiola et al. [48] | Serous, Non-serous | III, IV |
Gevaert et al. [49] | Serous, Endometrioid, Mucinous, Mixed | I, III, IV |
Bachvarov et al. [50] | Serous, Endometrioid, Clear cell | II, III, IV |
Netinatsunthorn et al. [51] | Serous | III, IV |
De Smet et al. [52] | Serous, Endometrioid, Mucinous, Mixed | I, III, IV |
Helleman et al. [53] | Serous, Endometrioid, Clear cell, Mucinous, Mixed, Poorly differentiated | I/II, III/IV |
Spentzos et al. [54] | Serous, Endometrioid, Clear cell, Mixed | I, II, III, IV |
Jazaeri et al. [55] | Serous, Endometrioid, Clear cell, Mixed, Undifferentiated, Carcinoma | II, III, IV |
Raspollini et al. [56] | Serous | IIIC |
Hartmann et al. [57] | Serous, Endometrioid, Mixed | II, III, IV |
Spentzos et al. [58] | Serous, Endometrioid, Clear cell, Mixed | I, II, III, IV |
Selvanayagam et al. [59] | Serous, Endometrioid, Clear cell, Undifferentiated | III, IV |
Iba et al. [60] | Serous, Endometrioid, Clear cell, Mixed | I, II, III, IV |
Kamazawa et al. [61] | Serous, Endometrioid, Clear cell | III, IV |
Vogt et al. [62] | NS | NS |